To The Top
Rebecca Whiting

INP,Ophthalmology,

Research Assistant Professor

whitingre@health.missouri.edu

(573) 882-8483

Ex vivo gene therapy for treatment of CLN2 Batten disease using a canine model.  We are pursuing combined treatment of the brain and retina to achieve amelioration of all neurologic symptoms in this disease